Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143540 |
| CAS No | NA |
| Mol.F. | C7H9N3O4 |
| Mol.Wt. | 199.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143541 |
| CAS No | NA |
| Mol.F. | C7H8ClN3O3 |
| Mol.Wt. | 217.61g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143542 |
| CAS No | NA |
| Mol.F. | C15H24N4O3 |
| Mol.Wt. | 308.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143543 |
| CAS No | NA |
| Mol.F. | C28H37N5O8 |
| Mol.Wt. | 571.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143544 |
| CAS No | NA |
| Mol.F. | C28H37N5O8 |
| Mol.Wt. | 571.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143545 |
| CAS No | NA |
| Mol.F. | C28H36N6O9 |
| Mol.Wt. | 600.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143546 |
| CAS No | NA |
| Mol.F. | C29H39N5O8 |
| Mol.Wt. | 585.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143547 |
| CAS No | NA |
| Mol.F. | C29H41N5O8 |
| Mol.Wt. | 587.67g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143548 |
| CAS No | NA |
| Mol.F. | C26H32N4O8 |
| Mol.Wt. | 528.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143549 |
| CAS No | NA |
| Mol.F. | C27H32N4O9 |
| Mol.Wt. | 556.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143550 |
| CAS No | NA |
| Mol.F. | C30H41N5O9 |
| Mol.Wt. | 615.68 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143551 |
| CAS No | NA |
| Mol.F. | C29H37N5O8 |
| Mol.Wt. | 583.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143552 |
| CAS No | NA |
| Mol.F. | C28H38N4O7 |
| Mol.Wt. | 542.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143553 |
| CAS No | NA |
| Mol.F. | C29H40N6O7 |
| Mol.Wt. | 584.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143554 |
| CAS No | NA |
| Mol.F. | C29H39N5O8 |
| Mol.Wt. | 585.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143555 |
| CAS No | NA |
| Mol.F. | C25H32N6O8 |
| Mol.Wt. | 544.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |